Equals 5, the leading AdTech platform revolutionizing pharmaceutical and healthcare marketing is excited to announce a strategic growth equity investment from Baleon Capital. This investment marks a ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

Expected use of approximately $25 million in first quarter of 2025 intended to preserve approximately 200,000 ADSs held as treasury shares ...

Samsung Biologics (KRX: 207940.KS), a global contract manufacturing and development organization (CDMO), today announced that ...

HAYWARD, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multiomic microbial identification services, ...

As political ad creators, we can take away some key lessons from this year’s lineup of Super Bowl ads. Here are four that ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

In the Phase 2 open-label Oral Anaphylm Symptom Intervention Study ("OASIS”) study, adults with Oral Allergy Syndrome (n=36) received Anaphylm under different conditions, including single and repeat ...

Interdisciplinary research teams strive for innovative approaches to cultural heritage preservation, funded by the National ...

The World Health Organization (WHO) and St. Jude Children's Research Hospital have commenced distribution of critically-needed childhood cancer medicines in 2 of 6 pilot countries, through the Global ...

Spade, the fastest and most accurate provider of real-time merchant intelligence for the card ecosystem, will partner with Stripe to power enriched merchant ...

Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...